KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Other Non-Current Liabilities (2016 - 2025)

Astrazeneca has reported Other Non-Current Liabilities over the past 11 years, most recently at $85.0 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $85.0 million for Q4 2025, down 90.77% from a year ago — trailing twelve months through Dec 2025 was $85.0 million (down 90.77% YoY), and the annual figure for FY2025 was $85.0 million, down 90.77%.
  • Other Non-Current Liabilities for Q4 2025 was $85.0 million at Astrazeneca, down from $921.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for AZN hit a ceiling of $4.3 billion in Q4 2022 and a floor of $85.0 million in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $1.2 billion (2023), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 111.81% in 2022 and later plummeted 90.77% in 2025.
  • Astrazeneca's Other Non-Current Liabilities stood at $2.0 billion in 2021, then soared by 111.81% to $4.3 billion in 2022, then tumbled by 72.58% to $1.2 billion in 2023, then dropped by 21.35% to $921.0 million in 2024, then plummeted by 90.77% to $85.0 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $85.0 million (Q4 2025), $921.0 million (Q4 2024), and $1.2 billion (Q4 2023) per Business Quant data.